Komori
CellSource (4880) · InitiativeFirst stated

Reduction in Tissue Collection Volume for Adipose-Derived Stem Cell Processing

First written in FY2024-Q2. . Latest entry: FY2024-Q2.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Reduction in Tissue Collection Volume for Adipose-Derived Stem Cell ProcessingA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2024-Q2First statedAnnual report

    「For the contract processing service for adipose-derived stem cells, we updated the processing method to reduce the amount of adipose tissue collected from patients to approximately 1/100 of the previous amount.」

    For the contract processing service for adipose-derived stem cells, the filing for the first time described an updated processing method that reduces the amount of adipose tissue collected from patients to approximately 1/100 of the previous amount.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for CellSource yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.